ACTIVE

APOTHEEK FRANSEN

Export PDF

Financial year 2025 · closed on 31/12/2025

Net result

175,9 k €

+12.1% YoY

Gross margin

386 k €

-3.3% YoY

Equity

887,1 k €

+5.2% YoY

Workforce

2,4 ETP

-4.0% YoY

What does APOTHEEK FRANSEN do?

APOTHEEK FRANSEN is a Private limited company incorporated in 1987. Its main activity is: Dispensing chemist in specialised stores. Its registered office is in Hoogstraten. It employs on average 2,4 ETP workers (FTE).

Legal situation

● Normal situation

BCE/KBO no. / VAT

BE 0432.655.137

Incorporation

11/12/1987

Legal form

Private limited company

Registered office

Vrijheid 160
2320 Hoogstraten · FlandreSee on map

Contributed capital

37 192,01 €

Latest accounts

31/12/2025

Average workforce

2,4 ETP

Activities (NACE)

47730Dispensing chemist in specialised stores· main 47730Dispensing chemist in specialised stores 52310Warehousing and support activities for transportation

Joint committees (2)

313
3130

Signals

ProfitableSolid equityLow riskGood liquidityPositive cashflowPositive EBITDAHealthy social debts

View the BCE/KBO Public Search record →

Health score

Available with a Rovalta subscriptionTry for 7 days

Recommended credit limit

✦ Verdict · Analyst summary

Financials

Trend over 18 financial years

	2025		2024		2023		2022		2019		2018		2017		2016		2015		2014		2013		2012		2011		2010		2009		2008		2007		2006
Income statement
Gross margin	386 k €	-3.3%	399 k €	+22.3%	326,3 k €	-13.8%	378,7 k €	+48.2%	255,6 k €	+2.7%	248,8 k €	+11.1%	224 k €	-2.5%	229,6 k €	+0.4%	228,6 k €	+6.9%	213,8 k €	+12.6%	189,9 k €	+31.1%	144,9 k €	+9.7%	132 k €	+21.9%	108,3 k €	-0.9%	109,2 k €	+43.2%	76,3 k €	+52.8%	49,9 k €	+19.5%	41,8 k €
EBITDA	228,4 k €	+2.8%	222,1 k €	+16.1%	191,4 k €	-12.7%	219,2 k €	+43.8%	152,5 k €	+17.0%	130,3 k €	-3.9%	135,6 k €	-1.2%	137,2 k €	-3.9%	142,8 k €	+25.2%	114,1 k €	+10.8%	102,9 k €	+12.1%	91,8 k €	+10.2%	83,3 k €	+12.5%	74,1 k €	-2.6%	76 k €	+48.1%	51,3 k €	+8.6%	47,3 k €	+23.0%	38,4 k €
Operating result	221,6 k €	+2.5%	216,2 k €	+18.0%	183,3 k €	-13.0%	210,7 k €	+45.5%	144,8 k €	+17.3%	123,4 k €	-3.1%	127,4 k €	+0.2%	127,1 k €	-5.2%	134 k €	+26.8%	105,7 k €	+9.0%	97 k €	+11.5%	87 k €	+11.8%	77,8 k €	+12.6%	69,1 k €	+2.2%	67,6 k €	+105%	33 k €	+38.8%	23,8 k €	+71.4%	13,9 k €
Net result	175,9 k €	+12.1%	156,9 k €	+1.7%	154,3 k €	+25.8%	122,6 k €	+1.5%	120,9 k €	+19.5%	101,1 k €	-0.7%	101,8 k €	-2.0%	103,9 k €	-3.2%	107,3 k €	+27.9%	83,9 k €	+5.7%	79,4 k €	+12.1%	70,8 k €	-9.4%	78,1 k €	+21.4%	64,4 k €	+14.3%	56,3 k €	+86.7%	30,2 k €	+49.2%	20,2 k €	+48.6%	13,6 k €
Balance sheet
Equity	887,1 k €	+5.2%	843,2 k €	+22.9%	686,4 k €	+29.0%	532,1 k €	+97.4%	269,6 k €	+26.1%	213,7 k €	-31.6%	312,6 k €	+19.9%	260,8 k €	-26.9%	356,9 k €	+19.1%	299,6 k €	-13.3%	345,7 k €	+16.7%	296,3 k €	+16.0%	255,5 k €	+23.2%	207,4 k €	+19.9%	173 k €	-39.7%	286,7 k €	+11.8%	256,6 k €	+8.2%	237,1 k €
Total assets	1 M €	-7.1%	1,1 M €	+17.8%	949,1 k €	+15.4%	822,2 k €	+98.4%	414,3 k €	-13.7%	479,9 k €	+12.9%	425,1 k €	-20.0%	531,5 k €	+10.8%	479,6 k €	-0.3%	481 k €	-0.6%	483,7 k €	+9.8%	440,7 k €	-2.9%	453,8 k €	-2.0%	463 k €	-2.5%	475,1 k €	+26.7%	374,8 k €	+2.1%	367,1 k €	-1.9%	374,1 k €
Cash	183 k €	-40.6%	308,4 k €	+175%	112,1 k €	-68.1%	350,7 k €	+144%	143,8 k €	+76.9%	81,3 k €	-31.6%	118,8 k €	-30.6%	171,2 k €	+3.7%	165,1 k €	+47.2%	112,2 k €	-2.1%	114,6 k €	+26.2%	90,8 k €	+7.5%	84,5 k €	-35.7%	131,4 k €	+14.4%	114,9 k €	-41.4%	196 k €	+184%	69,1 k €	+10.4%	62,6 k €
Debts	149,1 k €	-45.4%	273,1 k €	+4.6%	261,2 k €	-9.0%	287 k €	+99.0%	144,2 k €	-45.7%	265,9 k €	+138%	111,9 k €	-58.6%	270,3 k €	+121%	122,2 k €	-31.3%	177,8 k €	+29.1%	137,7 k €	-4.4%	143,9 k €	-27.2%	197,6 k €	-22.6%	255,2 k €	-15.4%	301,6 k €	+247%	87 k €	-20.4%	109,2 k €	-19.4%	135,5 k €
Other
Workforce	2,4 ETP	-4.0%	2,5 ETP	-3.8%	2,6 ETP	0.0%	2,6 ETP	0.0%	2,6 ETP	-3.7%	2,7 ETP	0.0%	2,7 ETP	+22.7%	2,2 ETP	+22.2%	1,8 ETP	-5.3%	1,9 ETP	+5.6%	1,8 ETP	+12.5%	1,6 ETP	+23.1%	1,3 ETP	+30.0%	1,0 ETP	0.0%	1,0 ETP	+25.0%	0,8 ETP		–		–

Estimate

Indicative valuation

As an indication, this company is worth

between 1 M€ and 2,5 M€

See the valuation

Governance

Board of directors

Seen on filing of 31/12/2025 · 1 active · 9 ended

Active mandates

Joeri Fransen

Director · since 22 juin 2021

Active

Ended mandates

GUIDO FRANSEN

Director · since 01 janvier 2009

Ended

JOERI FRANSEN

Managing director · since 01 janvier 2009

Ended

LUDRIFARMA BV

Director · since 01 janvier 2009 · 0808.379.885

Represented by Fransen Joeri

Ended

LUDRIFARMA BVBA

Director · since 01 janvier 2009 · 0808.379.885

Represented by JOERI FRANSEN

Ended

Annual accounts

Full financial information

	2025	2024	2023	2022	2021	2020
Type of account	Abridged model	Abridged model	Abridged model	Abridged model	Abridged model	Abridged model
Start of the financial year	01/01/2025	01/01/2024	01/01/2023	01/01/2022	01/01/2021	01/01/2020
Closing of the financial year	31/12/2025	31/12/2024	31/12/2023	31/12/2022	31/12/2021	31/12/2020
Length of the financial year	12 months	12 months	12 months	12 months	12 months	12 months
Filing date	30/07/2026	29/07/2025	09/07/2024	26/07/2023	30/09/2022	06/04/2021
General meeting	30/06/2026	30/06/2025	30/06/2024	16/05/2023	17/05/2022	16/03/2021
Currency of the financial year	EUR	EUR	EUR	EUR	EUR	EUR
NBB quality label	Satisfying controls	Satisfying controls	Satisfying controls	Satisfying controls	Satisfying controls	Satisfying controls

Ratios

Financial ratios

Looking for more information about this company?

Try for 7 days

Filings

Annual accounts filings

21 filings with the NBB

Model	Closing	General meeting	Filed	Language	Document
Abridged model	31/12/2025	30/06/2026	30/07/2026	Dutch	PDF
Abridged model	31/12/2024	30/06/2025	29/07/2025	Dutch	PDF
Abridged model	31/12/2023	30/06/2024	09/07/2024	Dutch	PDF
Abridged model	31/12/2022	16/05/2023	26/07/2023	Dutch	PDF
Abridged modelCorrection	31/12/2021	17/05/2022	30/09/2022	Dutch	PDF
Abridged model	31/12/2021	17/05/2022	12/07/2022	Dutch	PDF
Abridged model	31/12/2020	16/03/2021	06/04/2021	Dutch	PDF
Abridged model	31/12/2019	19/05/2020	28/05/2020	Dutch	PDF
Abridged model	31/12/2018	21/05/2019	07/06/2019	Dutch	PDF
Abridged model	31/12/2017	15/05/2018	13/06/2018	Dutch	PDF
Abridged model	31/12/2016	16/05/2017	13/06/2017	Dutch	PDF
Abridged model	31/12/2015	17/05/2016	06/06/2016	Dutch	PDF
Abridged model	31/12/2014	19/05/2015	20/05/2015	Dutch	PDF
Abridged model	31/12/2013	20/05/2014	11/06/2014	Dutch	PDF
Abridged model	31/12/2012	21/05/2013	23/05/2013	Dutch	PDF
Abridged model	31/12/2011	15/05/2012	04/06/2012	Dutch	PDF
Abridged model	31/12/2010	17/05/2011	23/05/2011	Dutch	PDF
Abridged model	31/12/2009	18/05/2010	20/05/2010	Dutch	PDF
Abridged model	31/12/2008	19/05/2009	20/05/2009	Dutch	PDF
Abridged model	31/12/2007	20/05/2008	28/05/2008	Dutch	PDF
Abridged model	31/12/2006	15/05/2007	14/06/2007	Dutch	PDF

Estimate

Indicative valuation

Order of magnitude

As an indication, this company is worth

between 1 M€ and 2,5 M€

The detail comes with the Business plan: low and high bounds, the valuation bridge for each financial year, transaction multiples by sector and size, group valuation and exports.

Discover the Business plan

Disclaimer

Indicative estimate based on public sector multiples and the filed annual accounts. It is neither a certified valuation nor financial or investment advice.

Governance

Board of directors

Seen on filing of 31/12/2025 · 1 active · 9 ended

Active mandates

Joeri Fransen

Director · since 22 juin 2021

Active

Ended mandates

GUIDO FRANSEN

Director · since 01 janvier 2009

Ended

JOERI FRANSEN

Managing director · since 01 janvier 2009

Ended

LUDRIFARMA BV

Director · since 01 janvier 2009 · 0808.379.885

Represented by Fransen Joeri

Ended

LUDRIFARMA BVBA

Director · since 01 janvier 2009 · 0808.379.885

Represented by JOERI FRANSEN

Ended

Shareholders

Ownership and network

Looking for more information about this company?

Try for 7 days

Belgian Official Gazette

Belgian Official Gazette publications

Restructuring15/10/2021
RUBRIEK HERSTRUCTURERING (FUSIE, SPLITSING, OVERDRACHT VERMOGEN, ENZ...) - WIJZIGING RECHTSVORM - STATUTEN (VERTALING, COÖRDINATIE, OVERIGE WIJZIGINGEN, ) - ONTSLAGEN - BENOEMINGEN - BENAMING - DOEL
PDF
Mandates13/04/2021
ONTSLAGEN - BENOEMINGEN
PDF
Mandates15/04/2020
ONTSLAGEN - BENOEMINGEN
PDF
Mandates10/07/2019
ONTSLAGEN - BENOEMINGEN
PDF
Mandates22/02/2013
ONTSLAGEN - BENOEMINGEN
PDF
Mandates27/01/2009
ONTSLAGEN - BENOEMINGEN
PDF
Mandates07/10/2005
KAPITAAL - AANDELEN - ONTSLAGEN - BENOEMINGEN - ALGEMENE VERGADERING - STATUTEN (VERTALING, COÖRDINATIE, OVERIGE WIJZIGINGEN, )
PDF

Source: Belgian Official Gazette

Competition

Similar companies

A company's peers, by sector and size, are included in the Business plan.

See the Business plan

2025
Annual accounts 2025175,9 k €↑
2024
Annual accounts 2024156,9 k €↑
2023
Annual accounts 2023154,3 k €↑
2022
Annual accounts 2022122,6 k €↑
2019
Annual accounts 2019120,9 k €↑
2018
Annual accounts 2018101,1 k €↓
2017
Annual accounts 2017101,8 k €↓
2016
Annual accounts 2016103,9 k €↓
2015
Annual accounts 2015107,3 k €↑
2014
Annual accounts 201483,9 k €↑
2013
Annual accounts 201379,4 k €↑
2012
Annual accounts 201270,8 k €↓
2011
Annual accounts 201178,1 k €↑
2010
Annual accounts 201064,4 k €↑
2009
Annual accounts 200956,3 k €↑
2008
Annual accounts 200830,2 k €↑
2007
Annual accounts 200720,2 k €↑
2006
Annual accounts 200613,6 k €
11/12/1987
IncorporationPrivate limited company

10/15	1 240 000	1 180 000	1 050 000
70	8 630 000	8 120 000	7 940 000
9904	412 000	388 000	301 000
17/49	2 970 000	3 140 000	3 380 000
9087	24,3	23,1	21,8

APOTHEEK FRANSEN

Overview

What does APOTHEEK FRANSEN do?

Trend over 18 financial years

Indicative valuation

Board of directors

Financials

Full financial information

Financial ratios

Annual accounts filings

Valuation

Indicative valuation

Directors & structure

Board of directors

Ownership and network

Publications

Belgian Official Gazette publications

Similar companies

Similar companies

Timeline